Login
Navigate Fool.com
Will JNJ beat
the market?

Johnson & Johnson

NYSE: JNJ

Community Rating: 4 Stars: Favorite

99.02 -0.18 (-0.18%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $99.57
Previous Close $99.20
Daily Range $98.79 - $99.71
52-Week Range $82.07 - $99.71
Market Cap $280.1B
P/E Ratio 18.97
Dividend (Yield) $2.64 (2.7%)
Ex-Dividend Date
Dividend Pay Date
02/21/14
03/11/14
Volume 3,123,683
Average Daily Volume 8,894,818
Current FY EPS $5.83

How do you think JNJ
will perform against the market?

Top JNJ Bull/Bear Pitches

 

mtinvest (< 20)
Submitted December 2, 2011

Buffett has been selling, while he should be buying. I don't quite understand it, because he doesn't need the cash.

0 Replies Reply Report this Post
 

acegdl007 (< 20)
Submitted January 20, 2011

J&amp;J is not a company that has experienced significant growth (in terms of stock price) over the past few years. It has mainly sustained its self on it's brand name recognition that has been signi … More

2 Replies Reply Report this Post

News & Commentary Rss Feed

The Dow Keeps Rising on Strong Earnings, But Health-Care Stocks Get Left Behind

Further gains for the Dow Jones Industrials reflected optimism about the new earnings season, but UnitedHealth Group and Johnson & Johnson were among the index's few losers. Find out why.

J&J's Headache-Relieving Earnings, Coke's Healthy Earnings in Emerging Markets, and Yahoo!'s "Turnar

Good evening, good lookin'. Here are the three things you need to know on April 16.

Why Coca-Cola and Twitter Jumped

The blue chips moved higher today led by a strong earnings report from Coca-Cola. Twitter also gained on an acquisition.

Will Today's Earnings Send the Dow Jones Industrials to New Record Highs?

Good earnings so far this week have the Dow Jones Industrials moving in the right direction. Are new all-time highs inevitable?

If Airbnb’s Worth $10B, HomeAway’s A Bargain

The Biggest Biotech Wins of the Week

Find out which biotech and pharmaceutical companies posted the best clinical results for the week ending April 11.

Johnson & Johnson's Earnings Report Impresses

Persistent strength in pharmaceuticals drives a strong beat, but valuation seems appropriate.

U.S. stocks end higher, rise for 2nd day in row

The 4 Stocks That Pulled the Markets Out of the Doldrums

Strong Earnings Push Coca-Cola and Johnson & Johnson Higher to Lead the Dow

Earnings season continues to impress, even if stocks aren't rising as a result.

See More JNJ News...

Sector

Healthcare

Industry

Drugs

Johnson & Johnson (JNJ) Description

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices. Website: http://www.jnj.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks